Source: Υπουργείο Υγείας (CY) Publisher: Remedica Ltd, Aharnon Str., Limassol Industrial Estate, 3056 Limassol, CYPRUS
Haloxen 5 mg tablets.
Haloxen 10 mg tablets.
| Pharmaceutical Form |
|---|
|
Tablet. Haloxen 5 mg tablets: Pink, round, normal convex tablets, scored with Remedica’s logo on one side and “HL 5” on the other side. The tablet can be divided into equal doses. Haloxen 10 mg tablets: Light yellow, round, normal convex tablets, scored with Remedica’s logo on one side. The tablet can be divided into equal doses. |
Each tablet contains haloperidol 5 mg and 10 mg respectively.
Excipient(s) with known effect:
These products contain 113,7 mg and 112,8 mg lactose respectively.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Haloperidol |
Haloperidol is an antipsychotic belonging to the butyrophenones group. It is a potent central dopamine type 2 receptor antagonist, and at recommended doses, has low alpha-1 antiadrenergic activity and no antihistaminergic or anticholinergic activity. |
| List of Excipients |
|---|
|
Haloxen 5 mg tablets: Microcrystalline cellulose Haloxen 10 mg tablets: Microcrystalline cellulose |
Haloxen 5 mg tablets: 30, 100 and 1000 tablets in blister packs.
Haloxen 10 mg tablets: 30 and 100 tablets in blister packs.
Not all pack-sizes may be marketed.
Remedica Ltd, Aharnon Str., Limassol Industrial Estate, 3056 Limassol, CYPRUS
Haloxen 5 mg tablets: 8589
Haloxen 10 mg tablets: 16307
Haloxen 5 mg tablets:
Date of first authorization: 11 January 1983
Date of latest renewal: 20 November 2009
Haloxen 10 mg tablets:
Date of first authorization: 19 October 1995
Date of latest renewal: 16 January 2012
| Drug | Countries | |
|---|---|---|
| HALOXEN | Cyprus, Malta, Singapore |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
